Bone Biologics Corp. Announces Closing of Public Offering and Uplisting to Nasdaq
BURLINGTON, Mass., October 18, 2021--(BUSINESS WIRE)--Bone Biologics Corp. (NASDAQ: BBLG) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion markets, today ann...